Related Experiment Video
Updated: Aug 23, 2025

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
Elevated Expression of LGR5 and WNT Signaling Factors in Neuroblastoma Cells With Acquired Drug Resistance
John Clark-Corrigall1, Svetlana Myssina1, Martin Michaelis2
1School of Nursing and Health Sciences, Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK.
Abstract:
Neuroblastoma (NB) is a pediatric solid cancer with high fatality, relapses, and acquired resistance to chemotherapy, that requires new therapeutic approaches to improve survival. LGR5 is a receptor that potentiates WNT/signaling pathway and has been reported to promote development and survival in several adult cancers. In this study we investigated LGR5 expression in a panel of NB cell lines with acquired resistance to vincristine or doxorubicin. We show LGR5-LRP6 cooperation with enhanced expression in drug resistant NB cell lines compared to parental cells, suggesting a role for LGR5 in the emergence of drug resistance, warranting further investigation.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Canonical Wnt Signaling Pathway

